A government advisory panel is discussing which schoolchildren should get Pfizer's pediatric COVID-19 vaccine. The FDA last week OK'd the use of kid-size doses for children ages 5 to 11, but the CDC also must sign off before vaccinations begin. (Nov. 2)
